You must have Credits on your Balance to download this sample
Infliximab Drug Monograph
Pages 6 (1506 words)
Infliximab Drug Monograph Name Institution Course Instructor Date Abstract Infliximab is a drug used to treat autoimmune diseases. It is traded by different company all over the world. The drug has been approved by the United States of America for treatment of various human diseases…
In the market, the drug is traded under the brand name of Remicade. The drug’s main manufacturing center is in United States of America. Infliximab Drug Monograph Infliximab is a drug which is used to treat patients who suffer from rheumatoid, Crohn’s diseases, ankylosing sponylitis, ulcerative colitis, and plaque psoriasis. The Infliximab drug can also be explained as an antibody drug which is used to treat chronic inflammatory diseases. It blocks the impact of necrosis factor alpha which is commonly labeled as (TNF alpha). Necrosis factor alpha is a substance manufactured by human cells, which plays a very crucial role in hiking inflammation in human body. Necrosis factor alpha is manufactured in the body immune system, hence Infliximab is used to reduce the effect of necrosis alpha factor in the body parts and most specifically. in the immune system. The generic name used for this drug is Infliximab while the brand name for the drug is Remicade. Patients with heart failure should not receive Infliximab unless tested by the doctor on their capability of sustaining the impact of the drug in the body. Additionally, patients with allergic reaction to Infliximab constitutes are also instructed not to use them (Frederic, 2010). Therapeutic Category The Infliximab therapeutic category is antirheumatic, GI anti-inflammatory (Frederic, 2010). ...
Not exactly what you need?